111 results
8-K
EX-99.1
BAX
Baxter International Inc.
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
and other key stakeholders in the areas of governance, strategy, risk management, and metrics and targets. Moving forward, Baxter expects to report against
8-K
EX-10.1
l1262dz
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
fj7ywhafnwl9 lfn
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
EX-99.1
3c10yo9mzk0fp6
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-2.1
h483ubvi gt6o1
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
vjiwg 4dfjk2rxg
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
424B3
i9ssp hr7m7g8oc3
12 May 22
Prospectus supplement
8:58am
8-K
pa6oeb
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
EX-99.1
pcbkvbb qry
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
EX-99.2
9x2rm6bdzy
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
78888ftd2sh3im i716
2 Dec 21
Entry into a Material Definitive Agreement
4:31pm